End Stage Renal DiseaseNCT06650215
The 2-minute Walk Test in Hemodialysis Patients
An observational study of End Stage Renal Disease, run by Kirsehir Ahi Evran Universitesi at 1 site in Turkey (Türkiye).
Trial summary
Walking tests are widely used to assess functional capacity in different populations because of their ease of administration, interpretability and representativeness of activities of daily living.The aim of our study was to investigate the validity and reliability of the 2-minute walk test in hemodialysis patients. Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- End Stage Renal Disease
- How many people
- 36 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- Nov 2024to Dec 2025
- How long will I take part?
- 1 Day
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Hemodialysis patients who are clinically stable, between 18 and 80 years of age, who are being followed up at the Hemodialysis Unit of Kırşehir Education and Research Hospital, who do not have any exclusion criteria, who can adapt to the evaluations to be made, who are willing to volunteer and who sign the informed consent form will be included in the study.
Who may be able to join
- Patients with end stage renal disease receiving hemodialysis
- Being clinically stable
- Being Aged between 18-80
- Volunteering to participate in this study
Who cannot join
- Having a musculoskeletal problem that may affect functional capacity measurement
- Having had a cardiac event in the past 3 months
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Kirsehir Ahi Evran University
Kırşehir
Merve Firat, +90 850 441 02 44 ext. 2490, mervefirat@ahievran.edu.tr
About this study
Official title: Validity and Reliability of the 2-minute Walk Test in Hemodialysis Patients
Walking tests are widely used to assess functional capacity in different populations because of their ease of administration, interpretability and representativeness of activities of daily living.The aim of our study was to investigate the validity and reliability of the 2-minute walk test in hemodialysis patients.
- Conditions
- End Stage Renal Disease
- Keywords
- Hemodialysis
- Medical subject headings
- Kidney Failure, Chronic
What is being measured
The primary outcome is the main question the study is designed to answer.
Exercise capacity
Will be assessed using the 2 minute walk test.
Measured: 5 minutes
Exercise capacity
Will be assessed using the 6 minute walk test.
Measured: 10 minutes
Muscle functions
Will be evaluated with 1 minute sit-stand test.
Measured: 1 minutes
Secondary outcomes (1)
Physical activity
Will be evaluated using International Phsyical Activity Questionnaire-Short form
Measured: 5 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Oct 2024
- Study startNov 2024 (estimated)
- Primary completionJun 2025 (estimated)
- Study completionDec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for End Stage Renal DiseaseStudies of the same condition, open and under way.
- More trials run by Kirsehir Ahi Evran UniversitesiThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 36 participants (estimated)
- Target duration
- 1 Day
Sponsor and investigators
- Lead sponsor
- Kirsehir Ahi Evran Universitesi
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Merve Firat, Kirsehir Ahi Evran Universitesi
- Investigators
- Merve Firat, Principal investigator, Kirsehir Ahi Evran Universitesi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06650215
- Sponsor's protocol ID
- 2024-13/113
- Status last verified
- Oct 2024
- First submitted
- 18 Oct 2024
- Last updated
- 5 Nov 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Nov 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Validity and Reliability of the 2-minute Walk Test in Hemodialysis Patients
- ClinicalTrials.gov ID
- NCT06650215
- Acronym / sponsor ID
- 2024-13/113
- Conditions
- End Stage Renal Disease
- Keywords
- Hemodialysis
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 36 participants (estimated)
- Lead sponsor
- Kirsehir Ahi Evran UniversitesiUniversity, hospital or other
- Study start
- Nov 2024 (estimated)
- Primary completion
- Jun 2025 (estimated)
- Study completion
- Dec 2025 (estimated)
- First posted
- 21 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Walking tests are widely used to assess functional capacity in different populations because of their ease of administration, interpretability and representativeness of activities of daily living.The aim of our study was to investigate the validity and reliability of the 2-minute walk test in hemodialysis patients.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Target follow-up
- 1 Day
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Hemodialysis patients who are clinically stable, between 18 and 80 years of age, who are being followed up at the Hemodialysis Unit of Kırşehir Education and Research Hospital, who do not have any exclusion criteria, who can adapt to the evaluations to be made, who are willing to volunteer and who sign the informed consent form will be included in the study.
Key inclusion criteria (4 listed)
- Patients with end stage renal disease receiving hemodialysis
- Being clinically stable
- Being Aged between 18-80
- Volunteering to participate in this study
Key exclusion criteria (2 listed)
- Having a musculoskeletal problem that may affect functional capacity measurement
- Having had a cardiac event in the past 3 months
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Exercise capacity
Time frame: 5 minutes
Will be assessed using the 2 minute walk test.
Exercise capacity
Time frame: 10 minutes
Will be assessed using the 6 minute walk test.
Muscle functions
Time frame: 1 minutes
Will be evaluated with 1 minute sit-stand test.
1 secondary outcome
Physical activity
Time frame: 5 minutes
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Nov 2024.
Related trials for End Stage Renal Disease
Active, not recruitingPhase 2
Safety and Efficacy of Empagliflozin in Hemodialysis
End Stage Renal Disease
Not yet recruiting
Hypothermic Kidney Machine Perfusion With Omnisol
End Stage Renal Disease (ESRD), Kidney Transplant
Recruiting
Guiding Optimal Blood Pressure Management in Peritoneal Dialysis Pilot Trial
End Stage Kidney Disease (ESKD), Hypertension (HTN)
RecruitingObservational study
Physical Impairments in Children With Chronic Renal Failure
Chronic Kidney Failure, Chronic Kidney Diseases
RecruitingPhase 1
A Study to Test the Safety of the Study Drug Fosmanogepix and How the Body Handles It in Adults With Severe Kidney Failure on Dialysis
End Stage Renal Disease on Dialysis, Adult
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Merve Firat principal investigator
Kirsehir Ahi Evran Universitesi
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of End Stage Renal Disease, run by Kirsehir Ahi Evran Universitesi at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 5 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Merve Firat (+90 850 441 02 44 ext. 2490, mervefirat@ahievran.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Exercise capacity (time frame: 5 minutes). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Nov 2024.